David A Sallman Selected Research

Immune Checkpoint Inhibitors

1/2021

Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Sallman Research Topics

Disease

30	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 12/2016
22	Neoplasms (Cancer) 05/2024 - 11/2007
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 01/2014
6	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 01/2020
4	Anemia 11/2023 - 01/2022
3	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2017
3	Febrile Neutropenia 04/2023 - 10/2021
3	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 12/2017
2	Disease Progression 12/2023 - 01/2017
2	Leukopenia 04/2023 - 10/2021
2	Neutropenia 01/2023 - 10/2021
2	Leukocytosis (Pleocytosis) 10/2021 - 12/2017
2	Splenomegaly 03/2018 - 12/2017
1	Pleural Effusion (Pleural Effusions) 04/2024
1	Cytopenia 02/2024
1	Residual Neoplasm 02/2024
1	Thrombocytopenia (Thrombopenia) 04/2023
1	Multiple Myeloma 03/2023
1	Hypersensitivity (Allergy) 01/2023
1	Bites and Stings (Sting) 01/2022
1	Inflammation (Inflammations) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Leukemia 11/2021
1	Pathologic Complete Response 01/2020
1	Disease Susceptibility (Diathesis) 10/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 04/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2007

Drug/Important Bio-Agent (IBA)

8	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 01/2020
5	eprenetapoptIBA 04/2023 - 01/2020
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2009
3	venetoclaxIBA 02/2024 - 01/2022
3	magrolimabIBA 11/2023 - 12/2020
3	InflammasomesIBA 01/2022 - 12/2016
3	ruxolitinibIBA 11/2021 - 12/2017
2	Monoclonal AntibodiesIBA 11/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 03/2023 - 01/2022
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2018
2	ClusterinIBA 06/2010 - 11/2007
2	Docetaxel (Taxotere)FDA Link 06/2010 - 11/2007
1	Dasatinib (BMS 354825)FDA Link 04/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024
1	ivosidenibIBA 01/2024
1	Core Binding Factors (Core-Binding Factor)IBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 03/2023
1	LigandsIBA 03/2023
1	proto-oncogene proteins pimIBA 01/2023
1	luspaterceptIBA 01/2023
1	HematinicsIBA 01/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Serine (L-Serine)FDA Link 09/2022
1	EnzymesIBA 09/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2022
1	Glutathione (Reduced Glutathione)IBA 09/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Biological FactorsIBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	GATA Transcription FactorsIBA 01/2022
1	axicabtagene ciloleucelIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	MDS 11IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020
1	lenzilumabIBA 01/2020
1	selinexorIBA 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	glasdegibIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2018
1	PrionsIBA 09/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2017
1	Thalidomide (Thalomid)FDA Link 12/2017
1	API 2IBA 06/2010
1	ResveratrolIBA 11/2007

Therapy/Procedure

30	Therapeutics 04/2024 - 10/2015
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Immunotherapy 05/2024 - 01/2017
1	Drug Tapering 10/2021
1	Precision Medicine 09/2021
1	Induction Chemotherapy 01/2020
1	Transplantation 01/2019
1	Salvage Therapy 03/2018